Search

Your search keyword '"Busceti MT"' showing total 21 results

Search Constraints

Start Over You searched for: Author "Busceti MT" Remove constraint Author: "Busceti MT" Search Limiters Full Text Remove constraint Search Limiters: Full Text
21 results on '"Busceti MT"'

Search Results

1. Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis

2. Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab

3. Role of biologics in severe eosinophilic asthma – focus on reslizumab

4. Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

5. Update on optimal use of omalizumab in management of asthma

6. The prevalence of sleep impairments and predictors of sleep quality among patients with asthma

8. Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

9. Application of proteomics and peptidomics to COPD

10. Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells

11. Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps.

12. Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility.

13. Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma.

14. Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma.

15. Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study.

16. Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma.

17. Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma.

18. Application of proteomics and peptidomics to COPD.

19. Update on anticytokine treatment for asthma.

20. Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells.

21. Molecular mechanisms underlying airway smooth muscle contraction and proliferation: implications for asthma.

Catalog

Books, media, physical & digital resources